Arterial Spin-Labeling Perfusion MR Imaging Demonstrates Regional CBF Decrease in Idiopathic Normal Pressure Hydrocephalus

J. Virhammar; K. Laurell; A. Ahlgren; E.-M. Larsson

doi:10.3174/ajnr.A5347

Abstract

BACKGROUND AND PURPOSE: Regional cerebral blood flow has previously been studied in patients with idiopathic normal pressure hydrocephalus with imaging methods that require an intravenous contrast agent or expose the patient to ionizing radiation. The purpose of this study was to assess regional CBF in patients with idiopathic normal pressure hydrocephalus compared with healthy controls using the noninvasive quantitative arterial spin-labeling MR imaging technique. A secondary aim was to compare the correlation between symptom severity and CBF.

MATERIALS AND METHODS: Differences in regional cerebral perfusion between patients with idiopathic normal pressure hydrocephalus and healthy controls were investigated with pseudocontinuous arterial spin-labeling perfusion MR imaging. Twenty-one consecutive patients with idiopathic normal pressure hydrocephalus and 21 age- and sex-matched randomly selected healthy controls from the population registry were prospectively included. The controls did not differ from patients with respect to selected vascular risk factors. Twelve different anatomic ROIs were manually drawn on coregistered FLAIR images. The Holm-Bonferroni correction was applied to statistical analyses.

RESULTS: In patients with idiopathic normal pressure hydrocephalus, perfusion was reduced in the periventricular white matter (P < .001), lentiform nucleus (P < .001), and thalamus (P < .001) compared with controls. Cognitive function in patients correlated with CBF in the periventricular white matter (r = 0.60, P < .01), cerebellum (r = 0.63, P < .01), and pons (r = 0.71, P < .001).

CONCLUSIONS: Using pseudocontinuous arterial spin-labeling, we could confirm findings of a reduced perfusion in the periventricular white matter, basal ganglia, and thalamus in patients with idiopathic normal pressure hydrocephalus previously observed with other imaging techniques.

ABBREVIATIONS:

ASL: arterial spin-labeling
DWMH: deep white matter hyperintensities
iNPH: idiopathic normal pressure hydrocephalus
MMSE: Mini-Mental State Examination
QRAPMASTER: Quantification of Relaxation Times and Proton density by Multiecho acquisition of a saturation recovery with Turbo spin-echo Readout

Idiopathic normal pressure hydrocephalus (iNPH) is a condition with balance and gait disturbances, cognitive dysfunction, and urinary incontinence.¹ The symptoms can be reversed with implantation of a shunt system, with improvement in 50%–80% of patients.^2⇓–4

Regional CBF has been assessed in patients with iNPH to find explanations for the pathophysiology and in search of better methods to identify shunt responders. Several studies have shown reduced perfusion in the frontal cortex, periventricular WM, basal ganglia, thalamus, and cerebellum in patients with iNPH compared with controls, but the results have been divergent.^{5⇓⇓⇓⇓⇓–11} In a recent study, reduced hippocampal CBF was reported as well.⁹

These previous studies have used different methods to estimate CBF: SPECT, PET, DSC MR imaging, and CT perfusion.^8,9,12,13 These methods require administration of a radioactive tracer or a contrast agent, and SPECT, PET, and CT expose the patient to ionizing radiation.

Pseudocontinuous arterial spin-labeling (ASL) is an MR imaging technique with the advantage of allowing quantitative measurements of CBF without injection of any contrast agent.¹⁴ The method is completely noninvasive, with a relatively short scan time (∼5 minutes) and can therefore easily be added to a standard MR imaging protocol. To the best of our knowledge, no previous study has investigated differences in CBF between healthy controls and patients with iNPH with an ASL technique.

The purpose of this study was to use ASL to investigate whether regional cerebral perfusion is reduced in patients with iNPH compared with healthy controls and whether the level of clinical symptoms correlates with CBF.

Materials and Methods

Patients and Healthy Controls

Sixty patients were prospectively and consecutively recruited from the waiting list of patients referred to Uppsala University Hospital for evaluation of suspected iNPH. Nine patients were excluded for participating in an ongoing multicenter study of the CSF tap test. Patients with complete inability to walk were excluded because of the intention to study the relationship between CBF and gait and balance function. Other exclusion criteria were secondary or congenital hydrocephalus, contraindications to MR imaging, older than 84 years of age, severe cognitive dysfunction with an inability to give informed consent, refusal to undergo evaluation or shunt surgery, and gait problems that could be explained by other known diseases. The inclusion process is illustrated in the flow chart (Fig 1). Of the 26 patients examined clinically, 17 were classified as having probable iNPH according to the iNPH guidelines.¹⁵ Six patients were classified as having possible iNPH, 1 because of only 1 triad symptom (gait disturbance), 1 due to severe white matter changes, 1 because of a small cyst communicating with 1 of the lateral ventricles, and 3 due to a history of head trauma, probably unrelated to the hydrocephalus. Three patients were considered unlikely to have iNPH, 2 because of symptoms of Parkinson disease and 1 with an aqueductal stenosis. The patients examined in this study have been described in detail in a previous study.¹⁶

Fig 1.

Flow chart describing the inclusion process of patients.

Controls were randomly recruited from the county of Uppsala using the Swedish population registry and were matched with patients with respect to age (±2 years) and sex. Exclusion criteria were any known neurologic disease, stroke, diabetes mellitus, history of myocardial infarction that required acute treatment or resulted in persistent electrocardiogram changes, dependence on walking aids, or any terminal disease. Antihypertensive medication, aspirin, and common pain medications were allowed. Information was sent to 105 potential elderly controls. Forty-nine did not reply; 31 responded that they did not want to participate or could not participate according to the exclusion criteria. The remaining 25 accepted participation and were examined clinically by a neurologist. MR imaging examination was not possible in 2 of the 25 controls because the MR imaging scanner was upgraded before those 2 controls were examined, and another 2 controls did not match any patient. Thus, a total of 21 matched pairs of patients (15 with probable iNPH and 6 with possible iNPH) and controls were available and included in the statistical analysis. The study was approved by the local ethics committee in Uppsala, Sweden.

Clinical Examination

Neurologists, especially trained physiotherapists, and occupational therapists performed the clinical examinations. Besides a standard neurologic examination, the tests included the modified Rankin Scale, Mini-Mental State Examination (MMSE), incontinence scale,¹⁷ Romberg test, and time and number of steps required to walk 10 m at a maximum pace. Tests of motor function were performed twice, and the mean result was used in the statistical analyses.

Imaging

Details of the imaging method, scanner protocol, and postprocessing have been described previously.¹⁶ The first MR imaging was performed between 8:00 am and 10:00 am. The second MR imaging was performed 60 minutes after the first scan to assess the repeatability of the method. The patients left the scanner after the first investigation. Between the investigations, the patients rested in the supine position in a quiet, isolated room next to the scanner. The patients were not allowed to use caffeine on the day of the MR imaging, and all transportation was performed with the patient in bed or in a wheelchair to minimize variations in CBF. Healthy controls were only examined once with MR imaging.

Scanner and Imaging Protocol

Imaging was performed with a 3T MR imaging scanner (Achieva; Philips Healthcare, Best, the Netherlands) with a 32-channel head coil. A 3D T1-weighted gradient-echo and a T2-weighted FLAIR sequence were included in the protocol. Perfusion MR imaging was performed with a background-suppressed pseudocontinuous ASL sequence, with a single-shot echo planar imaging readout, with the following protocol: FOV = 264 × 264 mm², in-plane resolution = 2.75 × 2.75 mm², section thickness = 5 mm, number of sections = 20, TR = 4100 ms, TE = 14.5 ms, label duration = 1650 ms, postlabeling delay = 1600 ms, and 30 repetitions. To allow quantitative CBF values, we obtained a fast reference scan.

Synthetic MR imaging data were acquired with the multisection, multiecho, and multisaturation delay sequence Quantification of Relaxation Times and Proton density by Multiecho acquisition of a saturation recovery with Turbo spin-echo Readout (QRAPMASTER).¹⁸ Because of technical problems, synthetic MR imaging data were not acquired in 2 patients and in 1 control.

Perfusion MR Imaging Postprocessing

For perfusion quantification, the compartment model proposed by Alsop and Detre was used.¹⁹ The magnetization difference (perfusion-weighted signal) is given by where M_0a is the arterial blood magnetization, α is the labeling efficiency, f is the perfusion, T_1a is the T1 of arterial blood, τ is the labeling duration, and w is the postlabeling delay. Labeling efficiency was set to 70%, T_1a was set to 1664 ms, and M_0a was estimated with the signal intensity of CSF (see Alsop and Detre¹⁹ for more detail).

As an anatomic reference, the FLAIR images were coregistered to the perfusion maps by using a 12-degree affine transform (elastix; http://elastix.isi.uu.nl/). To minimize the effect of nonideal image coregistration and to reduce the intrasubject variation caused by varying delineation of regions, we spatially smoothed the CBF maps (Gaussian kernel with 4-mm full width at half maximum, Fig 2).

Fig 2.

Example of ASL perfusion maps from a healthy control without (A) and with (B) smoothing, as well as from a patient with iNPH without (C) and with (D) smoothing.

ROIs and Morphologic Evaluations

Twelve different ROIs were drawn manually on transverse T2 FLAIR images using the in-house software Eval Gui (developed by Markus Nilsson, Lund University, Lund, Sweden). We covered the following regions: cerebellum, pons, high-convexity cortex, medial frontal cortex, lentiform nucleus, medial temporal lobe, supplementary motor area, thalamus, frontal WM, lateral WM, superior WM, and periventricular WM. The number of sections and voxels for all ROIs is listed in Table 1. Four different ROIs are illustrated in Fig 3, and all ROIs in both patients and controls are illustrated in the On-line Appendix. All sections of all scans were visually inspected, and care was taken not to include artifacts or large vessels in the ROIs. The ROIs were drawn by the first author (J.V., 4 years of experience) and reviewed by the last author (E.-M.L., >30 years of experience). When ROIs were drawn, the investigator was blinded to the patients' clinical data. CBF values were calculated for every voxel, and a mean CBF was provided in each ROI.

View this table:

Table 1:

Cerebral blood flow values in patients and controls^{^a}

Fig 3.

FLAIR images that were coregistered to the ASL images and used to draw ROIs. A–D, Healthy controls. E–H, Patients with iNPH. A and E, High-convexity cortex. B and F, Lateral periventricular WM. C and G, Frontal WM. D and H, Superior WM. All ROIs above were drawn in 2 adjacent sections, 1 of which is shown here.

For descriptive purposes, we assessed the following morphologic MR imaging features: the Evans index,²⁰ the callosal angle,²¹ and deep white matter hyperintensities (DWMH) according to the visual grading scale of Fazekas et al.²² Disproportionately enlarged subarachnoid space hydrocephalus was defined as a combination of enlarged ventricles (Evans index of >0.3), narrow sulci at the high convexity or parafalcine and dilated Sylvian fissures (Table 2).³ The measurements of morphologic features were performed by the last author (E.-M.L.). She was blinded to CBF data.

View this table:

Table 2:

Demographics and background data in patients and controls^{^a}

Volumetric Measurement

Measurements of CSF volumes were performed by using the QRAPMASTER sequence,¹⁸ which provides quantification of longitudinal relaxation time (T1), transverse relaxation time (T2), and proton density. The software SyMRI Brain Studio (SyntheticMR, Linköping, Sweden) uses combinations of T1, T2, and proton density to estimate voxelwise partial volumes of GM, WM, and CSF, which allow volumetric estimation of these tissues. The volume of both lateral ventricles was calculated semiautomatically in both patients and controls after manual delineation on each section that included the lateral ventricles.

Statistical Analysis

The mean CBF in each ROI from the 2 scans of the patients was used in the statistical analyses. Each patient was paired with an age- and sex-matched control. A paired-samples t test was used for the difference in CBF between patients and controls. Differences in descriptive data and comorbidity were analyzed with the Wilcoxon signed rank test or the McNemar test. Difference in age was tested with the Mann-Whitney U test. Correlations were assessed with the Spearman correlation. An intraclass correlation coefficient (2-way mixed, single measures) was used to calculate the repeatability of CBF between the 2 investigations in patients. For the analysis of CBF in patients and controls in the 12 ROIs, the Holm-Bonferroni correction for multiple comparisons was applied to reduce type I errors. Holm-Bonferroni correction works by sorting the N P values from the multiple tests and testing the smallest P value against α/N, the second smallest against α/(N-1), and so on. As soon as a null hypotheses is not rejected, all subsequent null hypotheses are also deemed not rejected, resulting in an effective significance threshold. With α = .05, the effective significance threshold for ROI analysis in patients and controls was P < .006. Correlations were tested among all 12 ROIs, and the 4 clinical tests as well as the 4 morphologic imaging features. Only correlations with r > 0.60 were considered strong and included in the results section. All analyses were performed with SPSS Statistics for Macintosh, Version 22.0 (IBM, Armonk, New York).

Results

Background Data

The radiologic morphologic measurements and the results of gait and balance tests, urgency, and MMSE differed markedly between patients and healthy controls (Table 2). However, there were no significant differences between patients and controls concerning age, the radiologic finding DWMH, and the use of antihypertensive drugs, acetylsalicylic acid, antidiabetic drugs, or statins, and there were no differences in the history of stroke, traumatic brain injury, meningitis, and previous or present smoking.

Cerebral Blood Flow

The CBF in all patients and controls is presented in Table 1. In patients, the CBF was significantly lower in the periventricular WM, lentiform nucleus, and thalamus after Holm-Bonferroni correction (Fig 4). In 3 patients with iNPH, the ASL maps contained vascular artifacts and apparent hypoperfusion in the brain parenchyma. If these 3 patients were excluded from statistical analyses, CBF was still significantly lower in patients in the periventricular WM, lentiform nucleus, and thalamus. There was no difference in age or symptom severity among the 3 patients with vascular artifacts compared with the other patients.

Fig 4.

Mean difference with 95% CI between patients with iNPH and healthy controls. MFC indicates the medial frontal cortex; HCC, high-convexity cortex; MTL, medial temporal lobe; SMA, supplementary motor area. The asterisk indicates a significant difference after Holm-Bonferroni correction.

Morphologic Features and CBF

In controls, there were negative correlations between the Evans index and perfusion in frontal WM (r = −0.75, P < .001), lateral WM (r = −0.73, P < .001), and periventricular WM (r = −0.66, P < .01). In controls, there were also negative correlations between quantified lateral ventricular volume with Synthetic MR imaging and perfusion in the frontal WM (r = −0.72, P < .001), lateral WM (r = −0.67, P < .01), periventricular WM (r = −0.65, P < .01), and medial frontal cortex (r = −0.61, P < .01). There were no correlations between ventricular volume and CBF in patients.

Clinical Symptoms and CBF

In patients, the MMSE score correlated significantly with CBF in the pons (r = 0.71, P < .001), cerebellum (r = 0.63, P < .01), and periventricular WM (r = 0.60, P < .01), but not in controls. Neither in patients nor in controls did gait, balance, or urgency incontinence correlate with CBF values. See On-line Tables 1 and 2 for all correlation coefficients in patients.

Repeatability

Repeatability for the CBF values obtained in the 2 investigations in patients is presented in Table 1 as intraclass correlation coefficients. The intraclass correlation coefficients were in the range of 0.72–0.92.

Volumetric Measurement

The median lateral ventricular volume in patients was significantly larger than in controls, 130 mL (interquartile range = 111–136 mL) and 31 mL (interquartile range, 24–54 mL), respectively.

Discussion

In this study, pseudocontinuous ASL, a noninvasive perfusion method without ionizing radiation or contrast agent, was used to compare cerebral perfusion between patients with iNPH and healthy controls. In agreement with previous studies using anatomic ROIs in patients with iNPH, CBF was reduced in the periventricular WM, basal ganglia, and thalamus.^5,9 There was a trend indicating that CBF was also reduced in the cerebellum in patients with iNPH, but the difference was not significant after Holm-Bonferroni correction. In patients, MMSE correlated significantly with CBF in the pons, cerebellum, and periventricular WM. The repeatability of the CBF measurements was acceptable to high, which strengthens our findings.

In the present study, reduced CBF in patients with iNPH was found in the basal ganglia, thalamus, and periventricular WM, whereas previous studies also reported hypoperfusion in the frontal cortex, temporal lobes, and cerebellum.^5,9,13 The more conservative correction for multiple analyses performed in our study could be one explanation for this difference, but another could be differences in the selection of healthy controls as well as the difference in imaging methods.

The mechanism of the reduced regional CBF in iNPH is likely multifactorial. One hypothesis is that transependymal passage of CSF into the parenchyma leads to reversal of interstitial fluid flow, initiating local CSF edema in the periventricular WM. The accumulation of interstitial fluid may cause local compression of small vessels and, more important, reduce elimination of vasoactive metabolites. The region mainly affected by hypoperfusion, according to this hypothesis, should be the periventricular WM, which is in line with our results and has also been reported by others.^6,9 The reduced CBF in the thalamus and lentiform nucleus may be an indirect result of periventricular WM edema, by affecting the penetrating arteries that supply the thalamus and lentiform nucleus.

The supplementary motor area, basal ganglia, thalamus, mesencephalon, or the white matter tracts connecting these regions have been suggested as the most important anatomic structures behind gait and balance disturbances in patients with iNPH.^23,24 There were no correlations between gait function and CBF in the present study. These findings indicate that the etiology of the gait disturbance in iNPH is complex and might be caused by factors other than reduced CBF.

However, there were correlations in the present study between impaired cognitive function measured with MMSE and reduced CBF in the pons, cerebellum, and periventricular WM. Perfusion in the brain stem has not been well-studied in iNPH, but Tullberg et al²⁵ reported a relative CBF increase in the mesencephalon in patients with improved wakefulness after shunt surgery. Disturbances in cognitive function, especially in attention and executive ability, have been reported after insults to the pons,²⁶ and such symptoms are often seen in iNPH as well.²⁷ The connection between impaired cognitive function and reduced CBF in the cerebellum is harder to explain; however, there are reports that the cerebellum is involved in cognitive function.^28,29

Hypertension and vascular risk factors³⁰ and MR imaging evidence of vascular disease such as DWMH are overrepresented in patients with iNPH.³¹ These vascular risk factors are associated with reduced CBF³²; therefore, differences in CBF could be overestimated if controls are a highly selected sample of healthy elderly. In the present study, the controls were randomly selected from the population, with a limited number of exclusion criteria. There was no significant difference in the burden of DWMH or the use of acetylsalicylic acid or antihypertensive drugs between patients and controls, which strengthens our findings.

In controls, there were correlations between the size of the lateral ventricles and reduced CBF in WM regions. A potential reason may be asymptomatic small-vessel disease with reduction of WM volume and secondary dilation of the lateral ventricles, indicating that even moderately enlarged ventricles may not be considered a normal aging phenomenon.

The pseudocontinuous ASL technique has some advantages compared with other perfusion methods. The repeatability in healthy controls and in patients with Alzheimer disease is high, and CBF values have been validated against PET.³³ Like PET, perfusion values can be quantified. Therefore, no reference regions are needed to calculate relative perfusion values. In SPECT and DSC perfusion, relative values are used, with the risk that pathologic perfusion in the reference regions may affect the relative perfusion values. In a recent study, CT perfusion was evaluated in iNPH and may be a promising alternative because it is available in many sites and is not as sensitive to artifacts from the shunt valve after shunt implantation as with MR imaging.⁸

In the iNPH guidelines from 2005, the SPECT-acetazolamide challenge is the only perfusion method mentioned as a supportive diagnostic technique.¹⁵ A SPECT-acetazolamide challenge requires a separate imaging investigation, is time-consuming, and exposes the patient to ionizing radiation from the injected tracer. The ASL sequence is rapid and noninvasive; these features make it ideal for research studies in patients with iNPH, but the diagnostic value of the method is uncertain. Although CBF differences were found between patients and controls on a group level, the effect may not be large enough in individual cases to allow the use of ASL as a supportive diagnostic technique in clinical routine.

The strength of this study was that prospectively and consecutively included patients were compared with age- and sex-matched controls who were randomly selected from the population.

Some limitations need to be considered. Three patients had a high intravascular signal with low signal intensity in the brain parenchyma, probably due to a longer arterial transit time than postlabeling delay.³⁴ Statistical analysis with and without these 3 patients did not show any significant differences; therefore, we chose not to exclude them. Individually optimized postlabeling delays would be preferable in elderly patients with pathologic CBF.

The CBF values in both our patients and controls were low compared with those reported in PET studies,^5,35 but they were in line with other ASL studies in patients with iNPH.³⁶ Also, it has been reported that quantified perfusion values are underestimated in elderly individuals with ASL.³⁷ Our main results were probably not affected by this limitation because we compared patients with age-matched controls.

White matter perfusion estimation with ASL is challenging, due to a longer arterial transit time and lower blood volume compared with gray matter. Thus, the WM perfusion signal had a low signal-to-noise ratio, and the corresponding results should be treated with some caution. On the other hand, 2 recent studies suggest that though pixel-wise analysis is challenging, ROI-based analysis of WM perfusion is feasible in single subjects.^38,39 This finding increases the credibility of our group-level results based on ROI analysis in 21 patients and 21 controls.

Spatial smoothing was applied to reduce the effects of nonideal coregistration but can potentially introduce partial volume effects on CBF measurements. This might have influenced the results of small ROIs with contamination of data from surrounding tissue.

The MMSE cognitive test used in this study may underestimate subcortical deficits that are very relevant in iNPH. More sophisticated neuropsychological tests could have revealed more information about the relationship between cognition and CBF in both patients and controls.⁴⁰

Conclusions

Pseudocontinuous ASL was used to compare perfusion of patients with iNPH versus healthy controls. In patients, perfusion values were reduced in the periventricular WM, basal ganglia, and thalamus, and there was a correlation between cognitive dysfunction and reduced CBF. Because ASL is a noninvasive quantitative perfusion method without ionizing radiation or contrast agent, it is a suitable perfusion method for research studies in patients with iNPH.

Acknowledgments

The authors thank Markus Nilsson for the software Eval Gui, Markus Fahlström for technical assistance, and Emma Jansson for assistance with examinations of healthy controls. The authors also thank our normal pressure hydrocephalus team and the MR imaging staff at Uppsala University Hospital, especially Britt-Mari Bolinder. Finally, the authors thank Selanders Stiftelse for its support.

Footnotes

Disclosures: Johan Virhammar—RELATED: Grant: Selanders Foundations, Comments: Swedish independent foundation*; UNRELATED: Payment for Lectures Including Service on Speakers Bureaus: Medtronic, Comments: I have received 1 educational lecture honoraria from Medtronic for 1 lecture. André Ahlgren—UNRELATED: Grant: Swedish Research Council.* *Money paid to the institution.
Johan Virhammar was supported by the independent Swedish foundation Erik, Karin och Gösta Selanders Stiftelse; Katarina Laurell received research grants from the Region Jämtland Härjedalen.

References

1.↵
2. Adams RD,
3. Fisher CM,
4. Hakim S, et al
. Symptomatic occult hydrocephalus with “normal” cerebrospinal-fluid pressure: a treatable syndrome. N Engl J Med 1965;273:117–26 doi:10.1056/NEJM196507152730301 pmid:14303656
CrossRef PubMed
2.↵
2. Klinge P,
3. Hellström P,
4. Tans J, et al
. One-year outcome in the European multicentre study on iNPH. Acta Neurol Scand 2012;126:145–53 doi:10.1111/j.1600-0404.2012.01676.x pmid:22571428
CrossRef PubMed
3.↵
2. Hashimoto M,
3. Ishikawa M,
4. Mori E, et al
; Study of INPH on neurological improvement (SINPHONI). Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res 2010;7:18 doi:10.1186/1743-8454-7-18 pmid:21040519
CrossRef PubMed
4.↵
2. Sundström N,
3. Malm J,
4. Laurell K, et al
. Incidence and outcome of surgery for adult hydrocephalus patients in Sweden. Br J Neurosurg 2017;31:21–27 doi:10.1080/02688697.2016.1229749 pmid:27619731
CrossRef PubMed
5.↵
2. Owler BK,
3. Momjian S,
4. Czosnyka Z, et al
. Normal pressure hydrocephalus and cerebral blood flow: a PET study of baseline values. J Cereb Blood Flow Metab 2004;24:17–23 doi:10.1097/01.WCB.0000093326.88757.49 pmid:14688613
CrossRef PubMed
6.↵
2. Momjian S,
3. Owler BK,
4. Czosnyka Z, et al
. Pattern of white matter regional cerebral blood flow and autoregulation in normal pressure hydrocephalus. Brain 2004;127:965–72 doi:10.1093/brain/awh131 pmid:15033897
CrossRef PubMed
7.↵
2. Sasaki H,
3. Ishii K,
4. Kono AK, et al
. Cerebral perfusion pattern of idiopathic normal pressure hydrocephalus studied by SPECT and statistical brain mapping. Ann Nucl Med 2007;21:39–45 doi:10.1007/BF03033998 pmid:17373335
CrossRef PubMed
8.↵
2. Ziegelitz D,
3. Arvidsson J,
4. Hellström P, et al
. Pre-and postoperative cerebral blood flow changes in patients with idiopathic normal pressure hydrocephalus measured by computed tomography (CT) perfusion. J Cereb Blood Flow Metab 2016;36:1755–66 doi:10.1177/0271678X15608521 pmid:26661191
CrossRef PubMed
9.↵
2. Ziegelitz D,
3. Starck G,
4. Kristiansen D, et al
. Cerebral perfusion measured by dynamic susceptibility contrast MRI is reduced in patients with idiopathic normal pressure hydrocephalus. J Magn Reson Imaging 2014;39:1533–42 doi:10.1002/jmri.24292 pmid:24006249
CrossRef PubMed
10.↵
2. Corkill RG,
3. Garnett MR,
4. Blamire AM, et al
. Multi-modal MRI in normal pressure hydrocephalus identifies pre-operative haemodynamic and diffusion coefficient changes in normal appearing white matter correlating with surgical outcome. Clin Neurol Neurosurg 2003;105:193–202 doi:10.1016/S0303-8467(03)00010-6 pmid:12860514
CrossRef PubMed
11.↵
2. Owler BK,
3. Pena A,
4. Momjian S, et al
. Changes in cerebral blood flow during cerebrospinal fluid pressure manipulation in patients with normal pressure hydrocephalus: a methodological study. J Cereb Blood Flow Metab 2004;24:579–87 doi:10.1097/00004647-200405000-00012 pmid:15129190
CrossRef PubMed
12.↵
2. Owler BK,
3. Pickard JD
. Normal pressure hydrocephalus and cerebral blood flow: a review. Acta Neurol Scand 2001;104:325–42 doi:10.1034/j.1600-0404.2001.00092.x pmid:11903086
CrossRef PubMed
13.↵
2. Larsson A,
3. Bergh AC,
4. Bilting M, et al
. Regional cerebral blood flow in normal pressure hydrocephalus: diagnostic and prognostic aspects. Eur J Nucl Med 1994;21:118–23 pmid:8162934
PubMed
14.↵
2. Wu WC,
3. Fernández-Seara M,
4. Detre JA, et al
. A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling. Magn Reson Med 2007;58:1020–27 doi:10.1002/mrm.21403 pmid:17969096
CrossRef PubMed
15.↵
2. Relkin N,
3. Marmarou A,
4. Klinge P, et al
. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 2005;57:S4–16; discussion ii-v pmid:16160425
CrossRef PubMed
16.↵
2. Virhammar J,
3. Laurell K,
4. Ahlgren A, et al
. Idiopathic normal pressure hydrocephalus: cerebral perfusion measured with pCASL before and repeatedly after CSF removal. J Cereb Blood Flow Metab 2014;34:1771–78 doi:10.1038/jcbfm.2014.138 pmid:25138210
CrossRef PubMed
17.↵
2. Hellström P,
3. Klinge P,
4. Tans J, et al
. A new scale for assessment of severity and outcome in iNPH. Acta Neurol Scand 2012;126:229–37 doi:10.1111/j.1600-0404.2012.01677.x pmid:22587624
CrossRef PubMed
18.↵
2. Warntjes JB,
3. Leinhard OD,
4. West J, et al
. Rapid magnetic resonance quantification on the brain: optimization for clinical usage. Magn Reson Med 2008;60:320–29 doi:10.1002/mrm.21635 pmid:18666127
CrossRef PubMed
19.↵
2. Alsop DC,
3. Detre JA
. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 1996;16:1236–49 doi:10.1097/00004647-199611000-00019 pmid:8898697
CrossRef PubMed
20.↵
2. Evans W
. An encephalographic ratio for estimating ventricular enlargement and cerebral atrophy. Arch Neurol Psychiatry 1942;47:931–37 doi:10.1001/archneurpsyc.1942.02290060069004
CrossRef
21.↵
2. Virhammar J,
3. Laurell K,
4. Cesarini KG, et al
. The callosal angle measured on MRI as a predictor of outcome in idiopathic normal-pressure hydrocephalus. J Neurosurg 2014;120:178–84 doi:10.3171/2013.8.JNS13575 pmid:24074491
CrossRef PubMed
22.↵
2. Fazekas F,
3. Chawluk JB,
4. Alavi A, et al
. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351–56 doi:10.2214/ajr.149.2.351 pmid:3496763
CrossRef PubMed
23.↵
2. Lundin F
. Idiopathic Normal Pressure Hydrocephalus, Aspects on Pathophysiology, Clinical Characteristics and Evaluation Methods [PhD thesis]. Linköping: Linköping University; 2012
24.↵
2. Hellstrom P
. The Neuropsychology of Idiopathic Normal Pressure Hydrocephalus [PhD thesis]. Gothenburg: University of Gothenburg; 2011
25.↵
2. Tullberg M,
3. Hellström P,
4. Piechnik SK, et al
. Impaired wakefulness is associated with reduced anterior cingulate CBF in patients with normal pressure hydrocephalus. Acta Neurol Scand 2004;110:322–30 doi:10.1111/j.1600-0404.2004.00325.x pmid:15476461
CrossRef PubMed
26.↵
2. Garrard P,
3. Bradshaw D,
4. Jäger HR, et al
. Cognitive dysfunction after isolated brain stem insult: an underdiagnosed cause of long term morbidity. J Neurol Neurosurg Psychiatry 2002;73:191–94 doi:10.1136/jnnp.73.2.191 pmid:12122182
Abstract/FREE Full Text
27.↵
2. Ogino A,
3. Kazui H,
4. Miyoshi N, et al
. Cognitive impairment in patients with idiopathic normal pressure hydrocephalus. Dement Geriatr Cogn Disord 2006;21:113–19 doi:10.1159/000090510 pmid:16374006
CrossRef PubMed
28.↵
2. E KH,
3. Chen SH,
4. Ho MH, et al
. A meta-analysis of cerebellar contributions to higher cognition from PET and fMRI studies. Hum Brain Mapp 2014;35:593–615 doi:10.1002/hbm.22194 pmid:23125108
CrossRef PubMed
29.↵
2. Moore DM,
3. D'Mello AM,
4. McGrath LM, et al
. The developmental relationship between specific cognitive domains and grey matter in the cerebellum. Dev Cogn Neurosci 2017;24:1–11 doi:10.1016/j.dcn.2016.12.001 pmid:28088647
CrossRef PubMed
30.↵
2. Malm J,
3. Graff-Radford NR,
4. Ishikawa M, et al
. Influence of comorbidities in idiopathic normal pressure hydrocephalus: research and clinical care—a report of the ISHCSF task force on comorbidities in INPH. Fluids Barriers CNS 2013;10:22 doi:10.1186/2045-8118-10-22 pmid:23758953
CrossRef PubMed
31.↵
2. Krauss JK,
3. Regel JP,
4. Vach W, et al
. White matter lesions in patients with idiopathic normal pressure hydrocephalus and in an age-matched control group: a comparative study. Neurosurgery 1997;40:491–95; discussion 495–96 pmid:9055287
CrossRef PubMed
32.↵
2. Bastos-Leite AJ,
3. Kuijer JP,
4. Rombouts SA, et al
. Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities. AJNR Am J Neuroradiol 2008;29:1296–301 doi:10.3174/ajnr.A1091 pmid:18451090
Abstract/FREE Full Text
33.↵
2. Xu G,
3. Rowley HA,
4. Wu G, et al
. Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer's disease. NMR Biomed 2010;23:286–93 doi:10.1002/nbm.1462 pmid:19953503
CrossRef PubMed
34.↵
2. Zaharchuk G,
3. Bammer R,
4. Straka M, et al
. Arterial spin-label imaging in patients with normal bolus perfusion-weighted MR imaging findings: pilot identification of the borderzone sign. Radiology 2009;252:797–807 doi:10.1148/radiol.2523082018 pmid:19703858
CrossRef PubMed
35.↵
2. Klinge PM,
3. Berding G,
4. Brinker T, et al
. A positron emission tomography study of cerebrovascular reserve before and after shunt surgery in patients with idiopathic chronic hydrocephalus. J Neurosurg 1999;91:605–09 doi:10.3171/jns.1999.91.4.0605 pmid:10507382
CrossRef PubMed
36.↵
2. Ivkovic M,
3. Reiss-Zimmermann M,
4. Katzen H, et al
. MRI assessment of the effects of acetazolamide and external lumbar drainage in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS 2015;12:9 doi:10.1186/s12987-015-0004-z pmid:25928394
CrossRef PubMed
37.↵
2. Ambarki K,
3. Wåhlin A,
4. Zarrinkoob L, et al
. Accuracy of parenchymal cerebral blood flow measurements using pseudocontinuous arterial spin-labeling in healthy volunteers. AJNR Am J Neuroradiol 2015;36:1816–21 doi:10.3174/ajnr.A4367 pmid:26251434
Abstract/FREE Full Text
38.↵
2. Wu WC,
3. Lin SC,
4. Wang DJ, et al
. Measurement of cerebral white matter perfusion using pseudocontinuous arterial spin labeling 3T magnetic resonance imaging: an experimental and theoretical investigation of feasibility. PLoS One 2013;8:e82679 doi:10.1371/journal.pone.0082679 pmid:24324822
CrossRef PubMed
39.↵
2. Skurdal MJ,
3. Bjornerud A,
4. van Osch MJ, et al
. Voxel-wise perfusion assessment in cerebral white matter with PCASL at 3T: is it possible and how long does it take? PLoS One 2015;10:e0135596 doi:10.1371/journal.pone.0135596 pmid:26267661
CrossRef PubMed
40.↵
2. Hellström P,
3. Edsbagge M,
4. Archer T, et al
. The neuropsychology of patients with clinically diagnosed idiopathic normal pressure hydrocephalus. Neurosurgery 2007;61:1219–26; discussion 1227–28 doi:10.1227/01.neu.0000306100.83882.81 pmid:18162901
CrossRef PubMed

Received March 16, 2017.
Accepted after revision June 12, 2017.

View Abstract

In this issue

Download PDF

Email Article

Citation Tools

Purchase

Cited By...

More in this TOC Section

Show more ADULT BRAIN

[1] 1.↵

Adams RD,
Fisher CM,
Hakim S, et al
. Symptomatic occult hydrocephalus with “normal” cerebrospinal-fluid pressure: a treatable syndrome. N Engl J Med 1965;273:117–26 doi:10.1056/NEJM196507152730301 pmid:14303656
CrossRef PubMed

[3] Adams RD,

[4] Fisher CM,

[5] Hakim S, et al

[6] 2.↵

Klinge P,
Hellström P,
Tans J, et al
. One-year outcome in the European multicentre study on iNPH. Acta Neurol Scand 2012;126:145–53 doi:10.1111/j.1600-0404.2012.01676.x pmid:22571428
CrossRef PubMed

[8] Klinge P,

[9] Hellström P,

[10] Tans J, et al

[11] 3.↵

Hashimoto M,
Ishikawa M,
Mori E, et al
; Study of INPH on neurological improvement (SINPHONI). Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res 2010;7:18 doi:10.1186/1743-8454-7-18 pmid:21040519
CrossRef PubMed

[13] Hashimoto M,

[14] Ishikawa M,

[15] Mori E, et al

[16] 4.↵

Sundström N,
Malm J,
Laurell K, et al
. Incidence and outcome of surgery for adult hydrocephalus patients in Sweden. Br J Neurosurg 2017;31:21–27 doi:10.1080/02688697.2016.1229749 pmid:27619731
CrossRef PubMed

[18] Sundström N,

[19] Malm J,

[20] Laurell K, et al

[21] 5.↵

Owler BK,
Momjian S,
Czosnyka Z, et al
. Normal pressure hydrocephalus and cerebral blood flow: a PET study of baseline values. J Cereb Blood Flow Metab 2004;24:17–23 doi:10.1097/01.WCB.0000093326.88757.49 pmid:14688613
CrossRef PubMed

[23] Owler BK,

[24] Momjian S,

[25] Czosnyka Z, et al

[26] 6.↵

Momjian S,
Owler BK,
Czosnyka Z, et al
. Pattern of white matter regional cerebral blood flow and autoregulation in normal pressure hydrocephalus. Brain 2004;127:965–72 doi:10.1093/brain/awh131 pmid:15033897
CrossRef PubMed

[28] Momjian S,

[29] Owler BK,

[30] Czosnyka Z, et al

[31] 7.↵

Sasaki H,
Ishii K,
Kono AK, et al
. Cerebral perfusion pattern of idiopathic normal pressure hydrocephalus studied by SPECT and statistical brain mapping. Ann Nucl Med 2007;21:39–45 doi:10.1007/BF03033998 pmid:17373335
CrossRef PubMed

[33] Sasaki H,

[34] Ishii K,

[35] Kono AK, et al

[36] 8.↵

Ziegelitz D,
Arvidsson J,
Hellström P, et al
. Pre-and postoperative cerebral blood flow changes in patients with idiopathic normal pressure hydrocephalus measured by computed tomography (CT) perfusion. J Cereb Blood Flow Metab 2016;36:1755–66 doi:10.1177/0271678X15608521 pmid:26661191
CrossRef PubMed

[38] Ziegelitz D,

[39] Arvidsson J,

[40] Hellström P, et al

[41] 9.↵

Ziegelitz D,
Starck G,
Kristiansen D, et al
. Cerebral perfusion measured by dynamic susceptibility contrast MRI is reduced in patients with idiopathic normal pressure hydrocephalus. J Magn Reson Imaging 2014;39:1533–42 doi:10.1002/jmri.24292 pmid:24006249
CrossRef PubMed

[43] Ziegelitz D,

[44] Starck G,

[45] Kristiansen D, et al

[46] 10.↵

Corkill RG,
Garnett MR,
Blamire AM, et al
. Multi-modal MRI in normal pressure hydrocephalus identifies pre-operative haemodynamic and diffusion coefficient changes in normal appearing white matter correlating with surgical outcome. Clin Neurol Neurosurg 2003;105:193–202 doi:10.1016/S0303-8467(03)00010-6 pmid:12860514
CrossRef PubMed

[48] Corkill RG,

[49] Garnett MR,

[50] Blamire AM, et al

[51] 11.↵

Owler BK,
Pena A,
Momjian S, et al
. Changes in cerebral blood flow during cerebrospinal fluid pressure manipulation in patients with normal pressure hydrocephalus: a methodological study. J Cereb Blood Flow Metab 2004;24:579–87 doi:10.1097/00004647-200405000-00012 pmid:15129190
CrossRef PubMed

[53] Owler BK,

[54] Pena A,

[55] Momjian S, et al

[56] 12.↵

Owler BK,
Pickard JD
. Normal pressure hydrocephalus and cerebral blood flow: a review. Acta Neurol Scand 2001;104:325–42 doi:10.1034/j.1600-0404.2001.00092.x pmid:11903086
CrossRef PubMed

[58] Owler BK,

[59] Pickard JD

[60] 13.↵

Larsson A,
Bergh AC,
Bilting M, et al
. Regional cerebral blood flow in normal pressure hydrocephalus: diagnostic and prognostic aspects. Eur J Nucl Med 1994;21:118–23 pmid:8162934
PubMed

[62] Larsson A,

[63] Bergh AC,

[64] Bilting M, et al

[65] 14.↵

Wu WC,
Fernández-Seara M,
Detre JA, et al
. A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling. Magn Reson Med 2007;58:1020–27 doi:10.1002/mrm.21403 pmid:17969096
CrossRef PubMed

[67] Wu WC,

[68] Fernández-Seara M,

[69] Detre JA, et al

[70] 15.↵

Relkin N,
Marmarou A,
Klinge P, et al
. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 2005;57:S4–16; discussion ii-v pmid:16160425
CrossRef PubMed

[72] Relkin N,

[73] Marmarou A,

[74] Klinge P, et al

[75] 16.↵

Virhammar J,
Laurell K,
Ahlgren A, et al
. Idiopathic normal pressure hydrocephalus: cerebral perfusion measured with pCASL before and repeatedly after CSF removal. J Cereb Blood Flow Metab 2014;34:1771–78 doi:10.1038/jcbfm.2014.138 pmid:25138210
CrossRef PubMed

[77] Virhammar J,

[78] Laurell K,

[79] Ahlgren A, et al

[80] 17.↵

Hellström P,
Klinge P,
Tans J, et al
. A new scale for assessment of severity and outcome in iNPH. Acta Neurol Scand 2012;126:229–37 doi:10.1111/j.1600-0404.2012.01677.x pmid:22587624
CrossRef PubMed

[82] Hellström P,

[83] Klinge P,

[84] Tans J, et al

[85] 18.↵

Warntjes JB,
Leinhard OD,
West J, et al
. Rapid magnetic resonance quantification on the brain: optimization for clinical usage. Magn Reson Med 2008;60:320–29 doi:10.1002/mrm.21635 pmid:18666127
CrossRef PubMed

[87] Warntjes JB,

[88] Leinhard OD,

[89] West J, et al

[90] 19.↵

Alsop DC,
Detre JA
. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 1996;16:1236–49 doi:10.1097/00004647-199611000-00019 pmid:8898697
CrossRef PubMed

[92] Alsop DC,

[93] Detre JA

[94] 20.↵

Evans W
. An encephalographic ratio for estimating ventricular enlargement and cerebral atrophy. Arch Neurol Psychiatry 1942;47:931–37 doi:10.1001/archneurpsyc.1942.02290060069004
CrossRef

[96] Evans W

[97] 21.↵

Virhammar J,
Laurell K,
Cesarini KG, et al
. The callosal angle measured on MRI as a predictor of outcome in idiopathic normal-pressure hydrocephalus. J Neurosurg 2014;120:178–84 doi:10.3171/2013.8.JNS13575 pmid:24074491
CrossRef PubMed

[99] Virhammar J,

[100] Laurell K,

[101] Cesarini KG, et al

[102] 22.↵

Fazekas F,
Chawluk JB,
Alavi A, et al
. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351–56 doi:10.2214/ajr.149.2.351 pmid:3496763
CrossRef PubMed

[104] Fazekas F,

[105] Chawluk JB,

[106] Alavi A, et al

[107] 23.↵

Lundin F
. Idiopathic Normal Pressure Hydrocephalus, Aspects on Pathophysiology, Clinical Characteristics and Evaluation Methods [PhD thesis]. Linköping: Linköping University; 2012

[109] Lundin F

[110] 24.↵

Hellstrom P
. The Neuropsychology of Idiopathic Normal Pressure Hydrocephalus [PhD thesis]. Gothenburg: University of Gothenburg; 2011

[112] Hellstrom P

[113] 25.↵

Tullberg M,
Hellström P,
Piechnik SK, et al
. Impaired wakefulness is associated with reduced anterior cingulate CBF in patients with normal pressure hydrocephalus. Acta Neurol Scand 2004;110:322–30 doi:10.1111/j.1600-0404.2004.00325.x pmid:15476461
CrossRef PubMed

[115] Tullberg M,

[116] Hellström P,

[117] Piechnik SK, et al

[118] 26.↵

Garrard P,
Bradshaw D,
Jäger HR, et al
. Cognitive dysfunction after isolated brain stem insult: an underdiagnosed cause of long term morbidity. J Neurol Neurosurg Psychiatry 2002;73:191–94 doi:10.1136/jnnp.73.2.191 pmid:12122182
Abstract/FREE Full Text

[120] Garrard P,

[121] Bradshaw D,

[122] Jäger HR, et al

[123] 27.↵

Ogino A,
Kazui H,
Miyoshi N, et al
. Cognitive impairment in patients with idiopathic normal pressure hydrocephalus. Dement Geriatr Cogn Disord 2006;21:113–19 doi:10.1159/000090510 pmid:16374006
CrossRef PubMed

[125] Ogino A,

[126] Kazui H,

[127] Miyoshi N, et al

[128] 28.↵

E KH,
Chen SH,
Ho MH, et al
. A meta-analysis of cerebellar contributions to higher cognition from PET and fMRI studies. Hum Brain Mapp 2014;35:593–615 doi:10.1002/hbm.22194 pmid:23125108
CrossRef PubMed

[130] E KH,

[131] Chen SH,

[132] Ho MH, et al

[133] 29.↵

Moore DM,
D'Mello AM,
McGrath LM, et al
. The developmental relationship between specific cognitive domains and grey matter in the cerebellum. Dev Cogn Neurosci 2017;24:1–11 doi:10.1016/j.dcn.2016.12.001 pmid:28088647
CrossRef PubMed

[135] Moore DM,

[136] D'Mello AM,

[137] McGrath LM, et al

[138] 30.↵

Malm J,
Graff-Radford NR,
Ishikawa M, et al
. Influence of comorbidities in idiopathic normal pressure hydrocephalus: research and clinical care—a report of the ISHCSF task force on comorbidities in INPH. Fluids Barriers CNS 2013;10:22 doi:10.1186/2045-8118-10-22 pmid:23758953
CrossRef PubMed

[140] Malm J,

[141] Graff-Radford NR,

[142] Ishikawa M, et al

[143] 31.↵

Krauss JK,
Regel JP,
Vach W, et al
. White matter lesions in patients with idiopathic normal pressure hydrocephalus and in an age-matched control group: a comparative study. Neurosurgery 1997;40:491–95; discussion 495–96 pmid:9055287
CrossRef PubMed

[145] Krauss JK,

[146] Regel JP,

[147] Vach W, et al

[148] 32.↵

Bastos-Leite AJ,
Kuijer JP,
Rombouts SA, et al
. Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities. AJNR Am J Neuroradiol 2008;29:1296–301 doi:10.3174/ajnr.A1091 pmid:18451090
Abstract/FREE Full Text

[150] Bastos-Leite AJ,

[151] Kuijer JP,

[152] Rombouts SA, et al

[153] 33.↵

Xu G,
Rowley HA,
Wu G, et al
. Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer's disease. NMR Biomed 2010;23:286–93 doi:10.1002/nbm.1462 pmid:19953503
CrossRef PubMed

[155] Xu G,

[156] Rowley HA,

[157] Wu G, et al

[158] 34.↵

Zaharchuk G,
Bammer R,
Straka M, et al
. Arterial spin-label imaging in patients with normal bolus perfusion-weighted MR imaging findings: pilot identification of the borderzone sign. Radiology 2009;252:797–807 doi:10.1148/radiol.2523082018 pmid:19703858
CrossRef PubMed

[160] Zaharchuk G,

[161] Bammer R,

[162] Straka M, et al

[163] 35.↵

Klinge PM,
Berding G,
Brinker T, et al
. A positron emission tomography study of cerebrovascular reserve before and after shunt surgery in patients with idiopathic chronic hydrocephalus. J Neurosurg 1999;91:605–09 doi:10.3171/jns.1999.91.4.0605 pmid:10507382
CrossRef PubMed

[165] Klinge PM,

[166] Berding G,

[167] Brinker T, et al

[168] 36.↵

Ivkovic M,
Reiss-Zimmermann M,
Katzen H, et al
. MRI assessment of the effects of acetazolamide and external lumbar drainage in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS 2015;12:9 doi:10.1186/s12987-015-0004-z pmid:25928394
CrossRef PubMed

[170] Ivkovic M,

[171] Reiss-Zimmermann M,

[172] Katzen H, et al

[173] 37.↵

Ambarki K,
Wåhlin A,
Zarrinkoob L, et al
. Accuracy of parenchymal cerebral blood flow measurements using pseudocontinuous arterial spin-labeling in healthy volunteers. AJNR Am J Neuroradiol 2015;36:1816–21 doi:10.3174/ajnr.A4367 pmid:26251434
Abstract/FREE Full Text

[175] Ambarki K,

[176] Wåhlin A,

[177] Zarrinkoob L, et al

[178] 38.↵

Wu WC,
Lin SC,
Wang DJ, et al
. Measurement of cerebral white matter perfusion using pseudocontinuous arterial spin labeling 3T magnetic resonance imaging: an experimental and theoretical investigation of feasibility. PLoS One 2013;8:e82679 doi:10.1371/journal.pone.0082679 pmid:24324822
CrossRef PubMed

[180] Wu WC,

[181] Lin SC,

[182] Wang DJ, et al

[183] 39.↵

Skurdal MJ,
Bjornerud A,
van Osch MJ, et al
. Voxel-wise perfusion assessment in cerebral white matter with PCASL at 3T: is it possible and how long does it take? PLoS One 2015;10:e0135596 doi:10.1371/journal.pone.0135596 pmid:26267661
CrossRef PubMed

[185] Skurdal MJ,

[186] Bjornerud A,

[187] van Osch MJ, et al

[188] 40.↵

Hellström P,
Edsbagge M,
Archer T, et al
. The neuropsychology of patients with clinically diagnosed idiopathic normal pressure hydrocephalus. Neurosurgery 2007;61:1219–26; discussion 1227–28 doi:10.1227/01.neu.0000306100.83882.81 pmid:18162901
CrossRef PubMed

[190] Hellström P,

[191] Edsbagge M,

[192] Archer T, et al

Main menu

User menu

Search

American Journal of Neuroradiology

Arterial Spin-Labeling Perfusion MR Imaging Demonstrates Regional CBF Decrease in Idiopathic Normal Pressure Hydrocephalus

Abstract

ABBREVIATIONS:

Materials and Methods

Patients and Healthy Controls

Clinical Examination

Imaging

Scanner and Imaging Protocol

Perfusion MR Imaging Postprocessing

ROIs and Morphologic Evaluations

Volumetric Measurement

Statistical Analysis

Results

Background Data

Cerebral Blood Flow

Morphologic Features and CBF

Clinical Symptoms and CBF

Repeatability

Volumetric Measurement

Discussion

Conclusions

Acknowledgments

Footnotes

References

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

News and Updates

Resources

Opportunities

American Society of Neuroradiology

Main menu

User menu

Search

Arterial Spin-Labeling Perfusion MR Imaging Demonstrates Regional CBF Decrease in Idiopathic Normal Pressure Hydrocephalus

Abstract

ABBREVIATIONS:

Materials and Methods

Patients and Healthy Controls

Clinical Examination

Imaging

Scanner and Imaging Protocol

Perfusion MR Imaging Postprocessing

ROIs and Morphologic Evaluations

Volumetric Measurement

Statistical Analysis

Results

Background Data

Cerebral Blood Flow

Morphologic Features and CBF

Clinical Symptoms and CBF

Repeatability

Volumetric Measurement

Discussion

Conclusions

Acknowledgments

Footnotes

References

In this issue

Citation Manager Formats

Jump to section

Related Articles

Cited By...

More in this TOC Section

Similar Articles

News and Updates

Resources

Opportunities

American Society of Neuroradiology